siRNA, Anti-CDC42BPA, 2'-MOE-modified(CAT#: SIRGT28334WQ-2MOE)

The product SIRGT28334WQ-2MOE is a type of small interfering RNA (siRNA) that targets CDC42BPA gene and regulates the expression of gene. The siRNA interferes with the expression of CDC42BPA gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2'-O-methoxyethyl (2'-MOE) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification 2'-O-methoxyethyl (2'-MOE)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_003607.3; NM_014826.4
Alternative Names MRCK; MRCKA; PK428
Related Diseases Myotonic Dystrophy
Purification HPLC
Target Gene
Gene ID 8476
Uniprot ID Q5VT25

Related Products